Divergent roles of STAT1 and STAT5 in malignancy as revealed by gene disruptions in mice.
about
8p12 stem cell myeloproliferative disorder: the FOP-fibroblast growth factor receptor 1 fusion protein of the t(6;8) translocation induces cell survival mediated by mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt/mTOR pathwaysAn immunologic portrait of cancerNuclear factor kappaB-dependent gene expression profiling of Hodgkin's disease tumor cells, pathogenetic significance, and link to constitutive signal transducer and activator of transcription 5a activityAssociation of IFN-gamma signal transduction defects with impaired HLA class I antigen processing in melanoma cell lines.Modulation of SOCS protein expression influences the interferon responsiveness of human melanoma cells.Genome-wide analysis reveals PADI4 cooperates with Elk-1 to activate c-Fos expression in breast cancer cells.Gross cystic disease fluid protein-15/prolactin-inducible protein as a biomarker for keratoconus disease.What does Stat3 do?The role of prolactin in mammary carcinoma.A distinct pre-existing inflammatory tumour microenvironment is associated with chemotherapy resistance in high-grade serous epithelial ovarian cancer.Hyper IgM syndrome presenting as chronic suppurative lung diseaseEnforced granulocyte/macrophage colony-stimulating factor signals do not support lymphopoiesis, but instruct lymphoid to myelomonocytic lineage conversion.Roles of unphosphorylated STATs in signaling.Curcumin induces proapoptotic effects against human melanoma cells and modulates the cellular response to immunotherapeutic cytokines.Bortezomib pre-treatment prolongs interferon-alpha-induced STAT1 phosphorylation in melanoma cellsThe functions of signal transducers and activators of transcriptions 1 and 3 as cytokine-inducible proteins.STAT transcription factors in hematopoiesis and leukemogenesis: opportunities for therapeutic intervention.Differential function of STAT5 isoforms in head and neck cancer growth control.Repression of STAT3, STAT5A, and STAT5B expressions in chronic myelogenous leukemia cell line K-562 with unmodified or chemically modified siRNAs and induction of apoptosis.STAT5a activation mediates the epithelial to mesenchymal transition induced by oncogenic RhoASerine-phosphorylated STAT1 is a prosurvival factor in Wilms' tumor pathogenesis.Constitutive tyrosine and serine phosphorylation of STAT4 in T-cells transformed with HTLV-I.Dissection of the cytoplasmic domains of cytokine receptors involved in STAT and Ras dependent proliferation.Role of Type I and II Interferons in Colorectal Cancer and Melanoma.Suppression of STAT5A and STAT5B chronic myeloid leukemia cells via siRNA and antisense-oligonucleotide applications with the induction of apoptosis.Suppression of STAT5A increases chemotherapeutic sensitivity in imatinib-resistant and imatinib-sensitive K562 cells.Leukemic transformation of normal murine erythroid progenitors: v- and c-ErbB act through signaling pathways activated by the EpoR and c-Kit in stress erythropoiesis.Neuregulin-1 activates the JAK-STAT pathway and regulates lung epithelial cell proliferation.Mapping normal and cancer cell signalling networks: towards single-cell proteomics.Bortezomib induces apoptosis by interacting with JAK/STAT pathway in K562 leukemic cells.Direct anti-cancer effect of oncostatin M on chondrosarcoma.Loss of Stat5a delays mammary cancer progression in a mouse model.Association between STAT1 activity and BRAF mutations in papillary thyroid carcinomas.
P2860
Q24548250-FA1F38EC-E14E-433F-8864-07EC3842E476Q27028000-FA1E5C4C-AC92-4D65-B532-722275B830F4Q28383134-AC910093-0465-4061-99B2-D636F22E581CQ30318493-1F036314-E36A-43E4-AD98-62D2C6A2A6AAQ33557548-7CE7AFF1-2037-4973-AAD7-00D1F37A9EBCQ33926858-63A2005B-35C7-4429-A782-35CFDCD2AEDFQ34535960-21F0C933-913A-45BA-8857-39884373DE58Q34627068-A73449F0-0EA4-4C1E-B643-689C329A92C5Q35067253-6D09E030-CEB2-4D3C-91E9-42798C146E4DQ35274995-FAFB109F-6DB4-4EB4-BD0D-BA11D5CCD5CAQ36356256-80A5D8E4-B76B-4210-83BC-FA07F565A6DEQ36370397-42AC9504-E1F2-41DE-A5A6-0D9EAF7FABE6Q37118445-49EBF10B-F0A4-4755-B329-4826AF5569B0Q37356349-E829358D-177F-4215-BD02-C33ECE5D870CQ37363932-27C50659-EC45-4921-A2D4-766D88B5F591Q37821935-C6F4FC6E-C9B3-4BE1-BCAD-0955DCA67DD0Q38116768-CA229D9A-0C05-48EA-B805-E527F0372C55Q38289837-3D871C55-2DC6-4097-A72B-4850BFB61BB1Q39262510-9C81CD15-5A78-460C-8212-0B9D56E1C250Q39697053-4A9DF84C-47AE-4194-B670-EDABB01FAC78Q40262816-66646087-0D6B-4B75-9E57-12004C3E71CDQ40344556-80FA3FF8-F3B3-4984-91A6-77E01C7B5831Q40729360-497E8BBD-C86C-4929-92AC-D363CD6E2412Q41123286-D20B4F8E-0EF7-4342-8D3E-C525965584C2Q41948418-417FBB3A-F686-40FD-8DD0-15D7F2471D71Q42904735-ED9A2CEA-EAF0-4541-9CE1-424DF7618551Q43663400-B63826D7-DA46-4E9E-9634-B376A9E63320Q44120928-AA955472-D0C4-4A33-979D-EF62F3FAB43BQ46307051-9FFCC3EF-757B-4AB8-B547-D87DBA237FE0Q50427017-98A0DDB1-55BE-4773-B999-DC61BDC62C4CQ53265964-1D55C606-4540-4291-9B7B-D3A9BAD68C5DQ53389128-40D46149-9C25-4835-9554-3651F5BD0105Q54516461-81167A74-4175-4962-AD70-A1B5433AE635
P2860
Divergent roles of STAT1 and STAT5 in malignancy as revealed by gene disruptions in mice.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Divergent roles of STAT1 and STAT5 in malignancy as revealed by gene disruptions in mice.
@ast
Divergent roles of STAT1 and STAT5 in malignancy as revealed by gene disruptions in mice.
@en
type
label
Divergent roles of STAT1 and STAT5 in malignancy as revealed by gene disruptions in mice.
@ast
Divergent roles of STAT1 and STAT5 in malignancy as revealed by gene disruptions in mice.
@en
prefLabel
Divergent roles of STAT1 and STAT5 in malignancy as revealed by gene disruptions in mice.
@ast
Divergent roles of STAT1 and STAT5 in malignancy as revealed by gene disruptions in mice.
@en
P356
P1433
P1476
Divergent roles of STAT1 and STAT5 in malignancy as revealed by gene disruptions in mice.
@en
P2093
P2888
P304
P356
10.1038/SJ.ONC.1203480
P407
P577
2000-05-01T00:00:00Z
P5875
P6179
1050735679